Johnson, B. C., Pauly, G. T., Rai, G., Patel, D., Bauman, J. D., Baker, H. L., . . . Hughes, S. H. (2012). A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. BioMed Central.

Johnson, Barry C., et al. A Comparison of the Ability of Rilpivirine (TMC278) and Selected Analogues to Inhibit Clinically Relevant HIV-1 Reverse Transcriptase Mutants. BioMed Central, 2012.

Johnson, Barry C., et al. A Comparison of the Ability of Rilpivirine (TMC278) and Selected Analogues to Inhibit Clinically Relevant HIV-1 Reverse Transcriptase Mutants. BioMed Central, 2012.